Effects of 4',7-dimethoxyflavanone on cell cycle arrest and apoptosis in human breast cancer MCF-7 cells

Eun Jeong Choi1, Jae In Lee, Gun-Hee Kim

  • 1Plant Resources Research Institute, Duksung Women's University, Seoul, 132-714, Korea.

Insights

4

Area of Science:

  • Pharmacology
  • Biochemistry
  • Molecular Biology

Background:

  • Flavonoids are plant-derived compounds with diverse biological activities.
  • Investigating novel anticancer agents is crucial for effective cancer therapy.

Purpose of the Study:

  • To evaluate the in vitro anticancer activity of 4',7-dimethoxyflavanone against human breast cancer cells.
  • To determine the mechanism of action of 4',7-dimethoxyflavanone-induced cytotoxicity.

Main Methods:

  • Human breast cancer MCF-7 cells and Chinese hamster ovary CHO-K1 cells were used.
  • Antiproliferative effects were assessed using various concentrations of 4',7-dimethoxyflavanone.
  • Cytotoxicity was measured by lactate dehydrogenase release.
  • Cell cycle distribution and apoptosis were analyzed via DNA fragmentation and flow cytometry.
  • Expression of CDK1 and cyclin B was examined.

Main Results:

  • 4',7-dimethoxyflavanone exhibited antiproliferative effects on MCF-7 cells with an IC(50) of 115.62 μM.
  • No significant cytotoxicity was observed in CHO-K1 cells.
  • Treatment induced cell cycle arrest at the G2/M phase and apoptosis in MCF-7 cells.
  • Increased levels of CDK1 and cyclin B were observed during G2/M phase arrest.

Conclusions:

  • 4',7-dimethoxyflavanone demonstrates selective anticancer activity against human breast cancer cells in vitro.
  • The compound induces apoptosis and cell cycle arrest, suggesting a potential therapeutic role.
  • Further investigation into 4',7-dimethoxyflavanone as an anticancer agent is warranted.